Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 24/04/2018 16:07:23 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 914.740 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2018 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,402.847 EPS = 2.87 |
| 27/02/2018 15:59:12 | BOOK CLOSURE FROM 18/04/2018 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2017 DIVIDEND = 40% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,925.414 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,981.023 EPS = 9.36 ANNUAL GENERAL MEETING WILL BE HELD ON 24/04/2018 BOOK CLOSURE TO 24/04/2018 |
| 26/10/2017 17:47:56 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2017 DIVIDEND = 30% PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,669.663 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,251.638 EPS = 6.96 BOOK CLOSURE FROM 10/11/2017 BOOK CLOSURE TO 17/11/2017 |
| 24/08/2017 15:16:54 | EPS = 4.58 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2017 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,485.933 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,426.275 |
| 24/04/2017 11:41:39 | EPS = 2.57 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2017 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,244.196 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 819.031 |